These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29398585)

  • 1. Does intraoperative success predict outcome in the treatment of urethral sphincter insufficiency with bulking agent?
    Pakkasjärvi N; Taskinen S
    J Pediatr Urol; 2018 Apr; 14(2):173.e1-173.e5. PubMed ID: 29398585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of continence procedures after failed endoscopic treatment with dextranomer-based implants (DEFLUX®).
    Alova I; Margaryan M; Verkarre V; Bernuy M; Lortat Jacob S; Lottmann HB
    J Pediatr Urol; 2012 Feb; 8(1):40-6. PubMed ID: 21277831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic injection of bulking agents in children with incontinence: dextranomer/hyaluronic acid copolymer versus polytetrafluoroethylene.
    Dyer L; Franco I; Firlit CF; Reda EF; Levitt SB; Palmer LS
    J Urol; 2007 Oct; 178(4 Pt 2):1628-31. PubMed ID: 17707036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic treatment of urinary incontinence in pediatric patients: 2-year experience with dextranomer/hyaluronic acid copolymer.
    Caione P; Capozza N
    J Urol; 2002 Oct; 168(4 Pt 2):1868-71. PubMed ID: 12352378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic treatment with dextranomer/hyaluronic acid for persistent incontinence after continent urinary reconstruction.
    Riachy E; Defoor WR; Reddy PP; Alam S; Noh PH; Sheldon C; Minevich EA
    J Endourol; 2015 Feb; 29(2):137-40. PubMed ID: 25265053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antegrade and retrograde endoscopic injection techniques for neurogenic sphincteric incontinence in children with neurogenic bladder.
    Lahlou M; Hukkinen M; Alova I; Botto N; Cheikhelard A; Blanc T; Lottmann HB
    J Pediatr Urol; 2021 Aug; 17(4):526.e1-526.e6. PubMed ID: 34119422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of bulking agent injection for persistent incontinence in cases of neurogenic bladder dysfunction.
    De Vocht TF; Chrzan R; Dik P; Klijn AJ; De Jong TP
    J Urol; 2010 Feb; 183(2):719-23. PubMed ID: 20022056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endoscopic management of urinary incontinence in neurogenic bladder due to spinal cord lesions in children].
    Dariane C; Peycelon M; Lallemant P; Forin V; Audry G
    Prog Urol; 2014 Jan; 24(1):39-45. PubMed ID: 24365627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes.
    Lightner DJ; Fox J; Klingele C
    Urology; 2010 Jun; 75(6):1310-4. PubMed ID: 20299087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endourethral injection of bulking agents for urinary incontinence in children.
    Godbole P; Bryant R; MacKinnon AE; Roberts JP
    BJU Int; 2003 Apr; 91(6):536-9. PubMed ID: 12656911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.
    Lee YK; Kuo HC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after dextranomer/hyaluronic acid bladder neck injection in patients with urethral incontinence following bladder neck repair.
    Stout M; Alpert S; Ching C; Dajusta D; Fuchs M; McLeod D; Jayanthi R; Ebert K
    J Pediatr Urol; 2023 Dec; 19(6):743-748. PubMed ID: 37596195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of endoscopic injection of dextranomer/hyaluronic acid based implants for treatment of urinary incontinence in children with neurogenic bladder.
    Alova I; Margaryan M; Bernuy M; Lortat-Jacob S; Lottmann HB
    J Urol; 2012 Nov; 188(5):1905-9. PubMed ID: 22998918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextranomer/hyaluronic acid bladder neck injection for persistent outlet incompetency after sling procedures in children with neurogenic urinary incontinence.
    DaJusta D; Gargollo P; Snodgrass W
    J Pediatr Urol; 2013 Jun; 9(3):278-82. PubMed ID: 22560990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative uses of dextranomer/hyaluronic acid copolymer: the efficacy of bladder neck injection for urinary incontinence.
    Misseri R; Casale AJ; Cain MP; Rink RC
    J Urol; 2005 Oct; 174(4 Pt 2):1691-3; discussion 1693-4. PubMed ID: 16148683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
    Kocaoglu C
    J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of bladder outlet procedures in children with neurogenic urinary incontinence.
    Noordhoff TC; van den Hoek J; Yska MJ; Wolffenbuttel KP; Blok BFM; Scheepe JR
    J Pediatr Urol; 2019 Feb; 15(1):35.e1-35.e8. PubMed ID: 30314731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the bulking effect of calcium hydroxyapatite and Deflux injection into the bladder neck for improvement of urinary incontinence in bladder exstrophy-epispadias complex.
    Eftekharzadeh S; Sabetkish N; Sabetkish S; Kajbafzadeh AM
    Int Urol Nephrol; 2017 Feb; 49(2):183-189. PubMed ID: 27896576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Low Urin Tract Symptoms; 2019 Jan; 11(1):66-71. PubMed ID: 29024564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.